Latest Breaking News On - Fabrice andr - Page 4 : comparemela.com

Palbociclib fails to benefit breast cancer subgroup, yielding lessons for future research

Adjuvant palbociclib combined with endocrine therapy failed to extend invasive DFS compared with endocrine therapy alone among patients with stage IIA hormone receptor-positive, HER2-negative breast cancer, according to study results.The findings, presented during an ASCO Plenary Series session, also showed the addition of the cyclin-dependent kinase (CDK)4/6 inhibitor did not improve other

'New era for cancer detection': Blood test spots multiple cancers without clear symptoms

The Galleri test also forecasts the location of the cancer, enabling medical professionals to expedite the subsequent investigation required to find and confirm a cancer. 

Dépistage précoce des cancers : l'intérêt de la prise de sang se confirme - A la une

Dépistage précoce des cancers : l'intérêt de la prise de sang se confirme

Une simple prise de sang pourrait permettre la détection de 50 types de cancer